(Q37126649)

18 August 2017

1 reference

title

Polymorphism in human organic cation transporters and metformin action (English)

1 reference

18 August 2017

1 reference

Hiroshi Takane

1

1 reference

18 August 2017

Eriko Shikata

2

1 reference

18 August 2017

Kenji Otsubo

3

1 reference

18 August 2017

Shun Higuchi

4

1 reference

18 August 2017

Ichiro Ieiri

5

1 reference

18 August 2017

publication date

1 April 2008

1 reference

18 August 2017

1 reference

18 August 2017

volume

9

1 reference

18 August 2017

issue

4

1 reference

18 August 2017

page(s)

415-422

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.4.415

18 August 2017

1 reference

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.4.415

Therapeutic comparison of metformin and sulfonylurea, alone and in various combinations. A double-blind controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.4.415

Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.4.415

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.4.415

Metabolic effects of metformin in non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.4.415

Effects of metformin on tyrosine kinase activity, glucose transport, and intracellular calcium in rat vascular smooth muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.4.415

Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.4.415

The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.4.415

Metformin is a superior substrate for renal organic cation transporter OCT2 rather than hepatic OCT1.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.4.415

Interactions of n-tetraalkylammonium compounds and biguanides with a human renal organic cation transporter (hOCT2).

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.4.415

Cloning and characterization of two human polyspecific organic cation transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.4.415

Involvement of organic cation transporter 1 in hepatic and intestinal distribution of metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.4.415

Involvement of organic cation transporter 1 in the lactic acidosis caused by metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.4.415

Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.4.415

Effect of genetic variation in the organic cation transporter 1, OCT1, on metformin pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.4.415

Human organic cation transporter (OCT1 and OCT2) gene polymorphisms and therapeutic effects of metformin.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.4.415

Measurement of the renal clearance of drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.4.415

Pharmacokinetics of metformin after intravenous and oral administration to man

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.4.415

Pharmacokinetics and pharmacodynamics of metformin in healthy subjects and patients with noninsulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.4.415

Disposition of metformin (N,N-dimethylbiguanide) in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.4.415

Efficacy of metformin in type II diabetes: results of a double-blind, placebo-controlled, dose-response trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.4.415

Transporters as a determinant of drug clearance and tissue distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.4.415

Reduction of metformin renal tubular secretion by cimetidine in man

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.4.415

Metformin transport by renal basolateral organic cation transporter hOCT2.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.4.415

Identification and functional characterization of a new human kidney-specific H+/organic cation antiporter, kidney-specific multidrug and toxin extrusion 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.4.415

Substrate specificity of MATE1 and MATE2-K, human multidrug and toxin extrusions/H(+)-organic cation antiporters

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.4.415

A human transporter protein that mediates the final excretion step for toxic organic cations

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.4.415

Identification and characterization of a novel monoamine transporter in the human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.4.415

Metformin transport by a newly cloned proton-stimulated organic cation transporter (plasma membrane monoamine transporter) expressed in human intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.4.415

Membrane localization and pH-dependent transport of a newly cloned organic cation transporter (PMAT) in kidney cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.4.415

Pharmacogenomics: translating functional genomics into rational therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.4.415

Genetic polymorphisms of drug transporters: pharmacokinetic and pharmacodynamic consequences in pharmacotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.4.415

Identification of genetic variations of the human organic cation transporter hOCT1 and their functional consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.4.415

Evolutionary conservation predicts function of variants of the human organic cation transporter, OCT1

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.4.415

Novel single nucleotide polymorphisms of organic cation transporter 1 (SLC22A1) affecting transport functions

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.4.415

Estimating the contribution of genes and environment to variation in renal drug clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.4.415

21 January 2018

Identifiers

DOI

10.2217/14622416.9.4.415

1 reference

18 August 2017

1 reference